Service Hotline: 400-826- 0806

News center

News
行情分析

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

Date: 2017-07-12
Views: 25

 

      On the afternoon of July 9th, TTGG Closed-door Meeting on Healthcare Industry Investment was successfully held in The Dragon. Partners of TTGG from the field of healthcare industry and responsible persons and senior managers of over twenty listed companies and industry leaders including Betta Pharmaceuticals, CONBA, Intmedic, Xianju Pharma, Jingxin Pharmaceutical, Starry, Yatai Pharmaceutical, Taloph, PKU HealthCare and Asia Pharmaceutical from inside and outside the province gathered together to discuss deeply on the development prospect and innovation of industry and finance integration of the pharmaceutical industry under the background of joint reformation for healthcare, medical insurance and medicines. Leaders from Zhejiang Council for Health Services Promotion and Zhejiang Pharmaceutical Industry Association also presented the meeting and offered their guidance.

       ZHU Yaochuan, the president of Zhejiang Council for Health Services Promotion delivered an opening speech themed 2017 Interpretation of New Medical Reform Policy, pointing out that the health and healthcare industry is the priority of China’s reform and development during the 13th Five-Year Plan period, that there is a huge space for the development of the industry in the future and that it is well worth investing the comprehensive health industry. He also signed the strategic cooperation agreement with the president of TTGG HE Xiangdong on behalf of Zhejiang Council for Health Services Promotion, reached strategic consensus and developed the comprehensive cooperative partnership on building comprehensive health investment platform at provincial level, better integrating industry chain and resources of relevant aspects, assisting leading enterprises from subdivided industry in transforming, upgrading and thriving as well as promoting the overall development of Zhejiang healthcare industry.

       ZHANG Yu, the managing partner of TTGG, introduced framework of the proposed Zhejiang healthcare industry fund of ten-billion scale. Healthcare industry features high industry barrier, strict government regulation and long industry chain, etc. However, the increasingly normalized policy supervision in turn forces the restructuring of industry ecosystem, making the industry integration and innovation upgrading more dependent on capitals. “TTGG Pharmaceutical R&D Fund”, as one of the cores of the framework and layout of TTGG overall healthcare industry fund, was officially initiated in the witness of industry insiders. This special fund centers on “quality drug varieties”, clutches investment opportunities brought by listing licensor system, consistent evaluation of generic drug and R&D of innovative drug, integrates such core resources of industry chain as drug approval property, R&D, channel and APIs to target the industry pain points; share the increment income from property value increase of quality varieties and market expansion during intensified integration of specialized division and collaboration of all links of the industry chain and the continuous stock integration and R&D innovation of drug varieties. As the leader of Zhejiang local private equity investment institutions, TTGG hopes to collaborate with all circles of healthcare industry to explore and build a provincial level healthcare industry investment and cooperation platform as well as accelerating the implementation of various special industry funds under professional management, so that the integration of industry and finance can be well realized.

       Four honored guests of the industry representing the attending industry parties and listed companies delivered brilliant keynote speeches on the meeting from different industry chain subdivision. Domestic Innovative Drug Development Trend and Investment Opportunity by president DING Lieming of Betta Pharmaceuticals presents us the promising development and implementation path of China innovative drug in the future, while Focus of Generic Drug Consistency Evaluation and Investment Strategy by Ms. LOU Jinfang (the president of Bio-Sincerity) elaborates the workflow of current generic drug consistency evaluation, points for attention and product selection. According to Transition Road and Reposition of Pharmaceutical Business under the “Two-Invoice” System by general manager JIANG Jufang of Int’l Group, the pharmaceutical circulation industry is in the critical window period for “upgrading and change”; the industry concentration will be greatly improved under the effect of two-invoice system; reshuffle, integration, transition and innovation will become the future development trend; and the new pattern mining and new technology application will be the first impetus. Lastly, deputy general manager LIU Xuanting of Xianju Pharma shared splendidly in How to Position the Drug Marketing under the New Medical Reform the new position of medication guideline and trinity layout of marketing strategy in clinical field, which offers a great inspiration. The meeting was successfully concluded by the enthusiastic involvement of participants and highly recognized by them.

       Principals of banks securities, trust and insurance institutions, financial and investment institutions including CCB, China CITIC Bank, Ping An Bank, CMBC. Wuchan Zhongda and JIC Group were also invited to this meeting. Despite their different fields, they unanimously believe that there is a great development and integration opportunity in healthcare field in the context of industrial policy change, and that the industry parties and capital parties should enhance their communication and mutual understanding to achieve win-win outcome through cooperation.

       President HE Xiangdong of TTGG addressed in the conclusion speech that as one of the first private equity investment institutions in China, TTGG has been devoted to the healthcare industry for over the past 17 years. It has been engaged in and supported the listing and industry M&A of over ten pharmaceutical enterprises and established solid and steady cooperation with many listed companies and relating enterprises in this industry. In 2016, our company put forward the concept of “professional focus” to build core competitiveness of various investment teams in each subdivision. Presently, we have 4 to 5 teams dedicating to the professional research and business linkage of healthcare sector, and have succeeded in PE listing, industry M&A, industry mother fund, overseas layout, etc. Based on years of experience and accumulation, TTGG expects to be proficient in healthcare field and facilitate the profound industry and finance integration within the field, so as to make a difference in “life-long health”.

      

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG Successfully Held the Closed-door Meeting on Healthcare Industry Investment

TTGG wishes to take advantage of this closed-door meeting to fully focus on and develop the healthcare field, dedicate itself to establishing the cooperation and sharing platform for partners in this industry and the financial industry, create long term effective cooperation and interaction mechanism and promote vigorously the integration of industry and finance; give full play to our

specialty, capital and resource advantages to assist the upstream and downstream enterprises in the healthcare industry chain in creating, changing and increasing value.

 

News / Related news More
2017 - 12 - 04
Yongquan Forum and Baishaquan · ZUFE Strategic Cooperation Signing Ceremony were held on the afternoon of 3rd December at Baishaquan M&A Block. Yongquan Forum is a major communication and project paring brand created by Baishaquan M&A Block. By hold sharing session and salon or giving speech each month, the forum serves as a communication platform for industry leaders with certai...
2017 - 11 - 30
CAI Gangqing, president and deputy secretary of the Party Committee of Anji Industrial Investment Development Group (IIDG) paid a visit to TTGG with 5 colleagues on the afternoon of 30th November. ZOU Jin, general manager and deputy secretary of the Party Committee of IIDG, FANG Jun, vice-general manager, and other department heads of IIDG attended the discussion. Our managing partner ZHANG Y...
2017 - 11 - 28
Zvi Heifetz, Israeli Ambassador to China, paid a visit to TTGG along with his wife on the evening of 28th November 2017. They were greeted by TTGG’s president YU Baohong. ZHANG Yu and GUO Feng, managing partners of TTGG, LI Xiang, general-manager of Investment Management Department, and other department heads also took part in the meeting.After greeting, YU briefly introduced TTGG’s hist...
2017 - 08 - 14
With the accelerating rhythm of the society, more and more white-collars are feeling stressed under modern work environments. In fact, such stress primarily results from the target-oriented time management. The key factors facilitating their abilities to improve time management efficiency and effectiveness are: how to find the causes of inefficiency, how to distinguish between the important things...
Copyright © 2016 - 2019 Zhejiang Paradise Silicon Valley Asset Management Group Co., Ltd
犀牛云提供企业云服务
X
1

QQ设置

3

SKYPE 设置

4

阿里旺旺设置

等待加载动态数据...

等待加载动态数据...

5

电话号码管理

  • 400-826-0806
6

二维码管理

等待加载动态数据...

等待加载动态数据...

展开